As prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps
Peer-Reviewed Publication
Updates every hour. Last Updated: 5-Jul-2025 02:10 ET (5-Jul-2025 06:10 GMT/UTC)
MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report, which includes 2023 data from 90 provider organizations – a robust response rate. The report features a foreword from Ginger Biesbrock, DSC, PA-C, FACC, executive vice president of MedAxiom Care Transformation Services, encouraging practical applications of the report’s data to design and implement team-based care models.
A new Perspective article published in the New England Journal of Medicine emphasizes the critical role of Fracture Liaison Services (FLS) in addressing the growing global burden of osteoporosis-related fractures, particularly hip fractures. “The burden of fragility fractures on health care systems is substantial, demanding coordination across multiple specialties including primary care, geriatrics, orthopedics, and rehabilitation,” said Douglas P. Kiel, MD, MPH, a senior scientist at Hebrew SeniorLife’s Hinda and Arthur Marcus Institute for Aging Research.
Study published in Nature Medicine on January 6 estimates that 2.2 million new cases of type 2 diabetes and 1.2 million new cases of cardiovascular disease occur each year globally due to consumption of sugar-sweetened beverages.
Key Takeaways:
A new study in JAMA Internal Medicine led by the Harvard Pilgrim Health Care Institute examined whether doxycycline post-exposure prophylaxis (doxyPEP) was associated with declines in bacterial sexually transmitted infections in routine care.
The study represents the largest cohort of doxyPEP recipients reported globally to date.
Findings showed doxyPEP was associated with a 79% reduction in chlamydia, 80% reduction in syphilis, and 12% reduction in gonorrhea.